|
Preclinical Development of Atr Inhibitor VE-822, Delivered Systemically in Nanoparticles, for Medulloblastoma Therapy |
University of North Carolina |
Cure4Cam Childhood Cancer Foundation, I Care I Cure |
|
Antibody Targeted Natural Killer Cell-Derived Extracellular Vesicles for the Treatment of Childhood Acute Lymphoblastic Leukemia and Neuroblastoma |
Children’s Hospital Los Angeles |
Cure4Cam Childhood Cancer Foundation, Flashes of Hope |
|
Optimizing Bispecific Antibody Therapy for Acute Leukemias |
Fred Hutchinson Cancer Research Center |
Cure4Cam Childhood Cancer Foundation |
|
Targeting the Six1/Eya Transcriptional Complex to Inhibit Pediatric Sarcomas |
University of Colorado Denver |
Cure4Cam Childhood Cancer Foundation |
|
Development of AAV Vectors for Efficient Targeting and Elimination of Osteosarcoma Tumor-Initiating Cells |
University of Florida |
Cure4Cam Childhood Cancer Foundation |
|
Two-pronged Cell Therapy: Engineering T Cells to Redirect Bystander T- and NK-Cells to Pediatric Cancer |
Baylor College of Medicine |
Cure4Cam Childhood Cancer Foundation |
|
HA-1 TCR T-cell Immunotherapy for Acute Leukemia |
Fred Hutchinson Cancer Research Center |
Cure4Cam Childhood Cancer Foundation, Marshall County Childhood Cancer Awareness Corporation |
|
Immunotherapy of Neuroblastoma with CAR.GD2 NKT Cells |
Baylor College of Medicine |
Cure4Cam Childhood Cancer Foundation |
|
Nanoparticle Delivery of Therapeutic Agents in Neuroblastomas |
Children’s Hospital of Philadelphia |
Cure4Cam Childhood Cancer Foundation |
|
Novel Therapeutic Targets in Relapse T-cell Acute Lymphoblastic Leukemia
|
Massachusetts General Hospital |
Cure4Cam Childhood Cancer Foundation |